AhlulBayt News Agency: With the licensing and release of six innovative products in the fields of cell therapy and tissue engineering by the Royan Research Institute, Iran has joined the group of countries possessing 110 approved advanced products in this field.
Researchers at Iran’s Royan Research Institute have successfully brought six products in the fields of cell therapy and tissue engineering to the stage of regulatory approval and market entry — an achievement that places Iran among the countries with 110 approved advanced products in this domain.
This milestone paves the way for greater patient access to innovative treatments and helps reduce dependence on imports of complex medical products.
Iran’s entry into the world’s 110 advanced products club, in addition to strengthening the country’s scientific standing in the region, can also contribute to the expansion of its knowledge-based economy.
/129
Your Comment